Zenas BioPharma, Inc.
ZBIO
$34.50
-$2.57-6.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.39% | -55.55% | 36.18% | -36.26% | -1.66% |
| Total Depreciation and Amortization | -8.33% | -47.83% | -30.30% | -8.33% | 2.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 164.16% | -0.88% | 4.00% | 73.55% | 62.45% |
| Change in Net Operating Assets | -171.04% | 158.23% | -199.91% | 95.11% | -11.87% |
| Cash from Operations | 1.48% | -12.66% | 3.90% | -24.13% | -0.32% |
| Capital Expenditure | -- | 100.00% | 75.68% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.66% | -30.18% | -2,256.08% | 86.32% | -- |
| Cash from Investing | 135.66% | -30.16% | -2,209.88% | 86.04% | -76,357.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -45.41% | 1,639.39% | -98.44% | -97.30% | 188,947.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -918.91% | 42.69% |
| Cash from Financing | 4,116.96% | 1,639.39% | -94.66% | -99.21% | 31.64% |
| Foreign Exchange rate Adjustments | 110.59% | -353.85% | -136.88% | 371.15% | -262.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.91% | -23.74% | -205.94% | -122.88% | 19.98% |